CLINICAL_TRIALS
trial_result
· 2023-03-14
Clinical Trial Update: Parcopa Versus Carbidopa-levodopa in a Single Dose Cross-over Comparison Study [Phase 4]
Summary
A Phase 4 crossover trial comparing Parcopa to carbidopa-levodopa in Parkinson's disease; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Baylor College of Medicine | Conditions: Parkinson's Disease | Phase 4 | Status: COMPLETED | Results posted: 2023-03-14